Patents by Inventor Andrew Lipchik

Andrew Lipchik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and Methods for Diagnostic Assessment and Treatment of Insulin Resistance and Hyperglycemia
    Publication number: 20240002474
    Abstract: Systems and methods to assess insulin resistance are described. Further, compounds and methods for treatment of insulin resistance or hyperglycemia are described. In some instances, immunoglobins of an individual are utilized in an insulin-stimulated mitochondrial function assay, which can be utilized to determine insulin resistance. In some instances, glycosylation, including sialylation, of immunoglobins of an individual are assessed, which can be utilized to assess insulin resistance. In some instances, immunoglobins, such as immunoglobin G, are utilized as a treatment for insulin resistance or hyperglycemia.
    Type: Application
    Filed: November 16, 2021
    Publication date: January 4, 2024
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Michael P. Snyder, Andrew Lipchik, Justin Annes, Sooyeon Lee, Anil Narasimha
  • Methods for Modulation of Acetyltransferase Activity and Applications Thereof Including Treatments
    Publication number: 20220196660
    Abstract: Methods to identify modulators of histone acetyltransferases are described. Modulators of histone acetyltransferases can be used to treat individuals. In some instances, modulators of histone acetyltransferases are utilized to treat individuals having a neoplasm.
    Type: Application
    Filed: April 22, 2020
    Publication date: June 23, 2022
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Joshua James Gruber, Benjamin Geller, Andrew Lipchik, Michael P. Snyder